kr.
155.00
Change
+1.50 +0.98%
Volume
Volume 22,670
Sep 27, 2023, 9:31 a.m.
Quotes are delayed by 20 min
Previous close
kr. 153.50
kr. 155.00
Change
+1.50 +0.98%
Day low
Day high
kr.153.45
kr.155.60

52 week low
52 week high
kr.134.45
kr.267.60

Market cap
kr.12.30B
Average volume
546,631
P/E ratio
11.05
Rev. per Employee
kr.5.67M
EPS
14.03
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on BAVA
-
GSK, Pfizer RSV Vaccines Get Tepid Endorsment
- Barron's Online
-
The First Vaccines for RSV Are Coming Soon. What to Know.
- Barron's Online
-
Emergent Biosolutions Upgraded After FDA Approves Narcan OTC Sales
- Barron's Online
-
GSK, Pfizer Duel Over RSV Vaccine Is Heating Up
- Barron's Online
-
Pfizer Jumps Ahead in Crowded Race for Lucrative RSV Vaccine
- Barron's Online
-
Monkeypox Crisis Drives U.S. to Shore Up Vaccine Supply
- Barron's Online
-
Investors Taking Comfort From the Fed Minutes Are Ignoring This Risk
- Barron's Online
-
Monkeypox Vaccine Maker Is Worried About Supplies
- Barron's Online
-
Cooling Inflation Heats Up the Stock Market
- Barron's Online
-
U.S. OKs plan to stretch monkeypox vaccine supply by using smaller doses
- Associated Press
-
U.S. Declares Monkeypox Emergency, Ramps Up Fight
- Barron's Online
-
White House Appoints Monkeypox Coordinator
- Barron's Online
-
U.S. signs off on 800,000 more doses of monkeypox vaccine
- Associated Press
-
4 Things to Know About the Company Making the Monkeypox Vaccine
- Barron's Online
- Loading more headlines...
Other News on BAVA
-
New Pfizer RSV Vaccine Rolls Out Into Headwinds of Hesitancy
- The Wall Street Journal Interactive Edition
-
FDA Approves GSK’s RSV Vaccine for Older Adults
- The Wall Street Journal Interactive Edition
-
Monkeypox Outbreak Leaves Risks, Questions in Its Wake
- The Wall Street Journal Interactive Edition
-
What Is Monkeypox? What to Know About Symptoms, Vaccines and How It Spreads
- The Wall Street Journal Interactive Edition
-
Monkeypox Antiviral Began as Bioterrorism Defense
- The Wall Street Journal Interactive Edition
-
Biden Administration Response to Monkeypox Outbreak Was Slow, Officials Say
- The Wall Street Journal Interactive Edition
-
FDA Adopts Policy to Stretch Monkeypox Vaccine Supplies
- The Wall Street Journal Interactive Edition
-
U.S. Declares Monkeypox a Public-Health Emergency
- The Wall Street Journal Interactive Edition
-
Moderna Profit Falls Amid Charges for Unused Covid Vaccines
- The Wall Street Journal Interactive Edition
-
Monkeypox Vaccine Demand Soars, and Just One Small Danish Company Makes It
- The Wall Street Journal Interactive Edition
-
What to Know About the Monkeypox Outbreak in the U.S.
- The Wall Street Journal Interactive Edition
-
FDA Clears Way for Use of Monkeypox Doses in U.S.
- The Wall Street Journal Interactive Edition
-
Monkeypox Caseload in U.S. Approaches World’s Highest
- The Wall Street Journal Interactive Edition
-
WHO Declares Monkeypox a Global Health Emergency
- The Wall Street Journal Interactive Edition
-
Bavarian Nordic Agrees to Boost Monkeypox-Vaccine Production
- The Wall Street Journal Interactive Edition
-
Monkeypox Vaccine Shortage Causes Frustration as Men Clamor for Doses
- The Wall Street Journal Interactive Edition
-
U.S. Expands Plan for Monkeypox Vaccinations in Effort to Curb Outbreak
- The Wall Street Journal Interactive Edition
-
U.K. Widens Monkeypox Vaccination Eligibility
- The Wall Street Journal Interactive Edition
-
U.S. Monkeypox Cases Double as Spread Continues Through Close Contact, CDC Says
- The Wall Street Journal Interactive Edition
-
Monkeypox Cases Concentrated in Specific Communities, CDC Says
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on BAVA
No News currently available for BAVA
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com